Presented By: Marc Davies, PhD & Stacie Chvatal, PhD
Webinar: Optimizing CAR structures to enhance efficacy in solid tumours; moving from linear to lateral architectures.
Webinar Abstract: Second generation Chimeric Antigen Receptor (CAR) T-cells have revolutionised the treatment of B-cell and plasma cell malignancies, achieving potent and durable responses across a number of indications. Unfortunately, efficacy of CAR T-cell therapy against the vast majority of solid tumours has been underwhelming...
Labroots on Social:
Facebook: / labrootsinc
Twitter: / labroots
LinkedIn: / labroots
Instagram: / labrootsinc
Pinterest: / labroots
SnapChat: labroots_inc
Негізгі бет Ғылым және технология Optimizing CAR structures to enhance efficacy in solid tumours; moving from linear to lateral...
Пікірлер